Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis Wasit Wongtrakul; Natthinee Charatcharoenwitthaya; Phunchai Charatcharoenwitthaya;

Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASH Bradley Jermy; Jack Brownrigg; Pavel Strnad; Rohit Loomba;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;